 |
 Video: What is a Stock Split?
|
|
|
| Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin. According to our Axogen stock split history records, Axogen has had 0 splits. | |
|
Axogen (AXGN) has 0 splits in our Axogen stock split history database.
Looking at the Axogen stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Axogen shares, starting with a $10,000 purchase of AXGN, presented on a split-history-adjusted basis factoring in the complete Axogen stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$2.96 |
|
| End price/share: |
$6.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
119.59% |
|
| Average Annual Total Return: |
8.18% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$21,951.78 |
|
| Years: |
10.00 |
|
|
|
|
|
